While IL-10 is conventionally regarded as an anti-inflammatory cytokine, emerging evidence indicates that it exerts a dual role depending on the pathological context (16): in chronic airway diseases and specific tumor microenvironments, IL-10–mediated immunosuppression may impair pathogen clearance and contribute to persistent inflammation. The gene discussed is IL10; the disease is neoplasm.